The MAJIC-PV study offers new insights into the use of ruxolitinib for polycythemia vera patients intolerant to hydroxycarbamide, emphasizing its role in extending survival and improving response rates.

The discovery of lactate’s potential to rejuvenate immune cells and combat cancer opens up exciting new avenues in the field of immunotherapy. Dive in to uncover how a simple metabolic byproduct could drastically reshape cancer treatment strategies.

Take part in an engaging multidisciplinary discussion on the evolving dynamics of hepato-pancreatico-biliary cancers. Discover, learn, and prepare to integrate these new strategies into your clinical practice.

In light of the Supreme Court’s recent ruling, it’s more imperative than ever for healthcare practitioners to fortify their commitment towards equitable healthcare, unmask health disparities, and staunchly combat racial prejudice and discrimination.

Gain insight into how a shift in cellular environment and UV radiation exposure can instigate additional mutations, deepening our understanding of the evolution and development of rare and complex malignancies such as BPDCN.

Learn about a ground-breaking strategy for treating uncommon brain tumors like papillary craniopharyngiomas (PCPs), where precision medicine and BRAF/MEK inhibitors marked a major improvement in brain cancer treatment by drastically reducing tumor size.